ARV Supply Expected To Stabilise As Court Battle Ends

Monday, November 18, 2019

The supply of Anti Retroviral (ARV) drugs is expected to stabilise after government won a marathon court battle against one of the major suppliers, Portfolio Pharmaceuticals.

The company had cited irregularities in awarding of a tender for the supply of the drugs, after Portfolio Pharmaceuticals lost a significant share of the market to other players.

Following that, a lengthy court battle ensued, which had affected supply, with some patients receiving a weekly, rather than their monthly allocations.

Already have an active account? Log in here.

Or Sign up and get unlimited access to premium articles.

'I was deceived'

Larona Makhaiza | 9 h ago

Fierce battle looms in BPF Nata-Gweta primaries

Chakalisa Dube | 15 h ago

BPF to win all Serowe constituencies

Innocent Selatlhwa | 15 h ago

BDP councillor withdraws candidacy, decries voters roll manipulation

Tsaone Basimanebotlhe | 15 h ago

BDP primaries: More fireworks, twists and turns

Tsaone Basimanebotlhe,Goitsemodimo Kaelo | 15 h ago

Choppies' P1m Olympic incentive

Calistus Kolantsho | 17 h ago

Masole gears for third Chess Olympiad

Calistus Kolantsho | 18 h ago

Wildebeests on the cusp of rugby history

CALISTUS KOLANTSHO | 18 h ago

BDP primaries leave a lot to be desired

The BDP as a party known to have ample resources has always held its primaries well in time, but this time around that was not the case. The first leg of the primaries was held last weekend, with the final leg being billed for the coming weekend. This time around, the BDP failed to shine in its primary elections. The elections were chaotic; most if not all polling stations didn't open at the specified time of 6am. Loyal BDP members braved the...

The Monitor Editor | 22 July 2024

About us

Mmegi is the leading independent source of breaking news, latest news, current
affairs, Politics, Business, Sport, debates, analysis, and entertainment news in Botswana.

Explore

More

ARV Supply Expected To Stabilise As Court Battle Ends

The supply of Anti Retroviral (ARV) drugs is expected to stabilise after government won a marathon court battle against one of the major suppliers, Portfolio Pharmaceuticals.